Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 82 for

Edit search filters
  1. Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant

    Rochester, MN

  2. A Study Of The Outcomes Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease

    Rochester, MN

  3. A Study To Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant In Participants With Newly Diagnosed Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  4. Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients with Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System

    Rochester, MN

  5. Tai Chi To Optimize Transplant Outcomes For Multiple Myeloma

    Jacksonville, FL

  6. Clinical Trial Of Upfront Haploidentical Or Unrelated Donor Bmt To Restore Normal Hematopoiesis In Aplastic Anemia

    Rochester, MN

  7. Identifying Best Approach In Improving Quality Of Life And Survival After A Donor Stem Cell Transplant In Older, Medically Infirm, Or Frail Patients With Blood Diseases

    Rochester, MN

  8. A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

    Rochester, MN

  9. Hematopoietic Stem Cell Transplant Survivors Study (HTSS Study)

    Rochester, MN

  10. Presatovir In Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection Of The Upper Respiratory Tract

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer